These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 54813)

  • 21. Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.
    Noworolska A; Harłozińska A; Richter R; Brodzka W
    Br J Cancer; 1985 Mar; 51(3):371-7. PubMed ID: 3882113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of t(8;21)(q22;q22) in myeloperoxidase-positive, myeloid surface antigen-negative acute myeloid leukemia.
    Arber DA; Glackin C; Lowe G; Medeiros LJ; Slovak ML
    Am J Clin Pathol; 1997 Jan; 107(1):68-73. PubMed ID: 8980370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
    Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D
    Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane HLADr (Ia-like) and cytoplasmic chloroacetate esterase expression by blast cells in myeloid leukaemia.
    Scott CS; Limbert HJ
    Med Lab Sci; 1986 Jan; 43(1):88-90. PubMed ID: 3457232
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunodiagnosis of acute nonlymphocytic leukemia.
    Hurwitz CA; Strauss LC; Civin CI
    Immunol Ser; 1990; 53():265-87. PubMed ID: 2100559
    [No Abstract]   [Full Text] [Related]  

  • 26. [Foetal antigens on leukaemia cells (author's transl)].
    Thränhardt H; Zintl F; Milleck J; Plenert W
    Arch Geschwulstforsch; 1978; 48(8):750-5. PubMed ID: 288321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human leukemia antigens: partial isolation and characterization.
    Metzgar RS; Mohanakumar T; Green RW; Miller DS; Bolognesi DP
    J Natl Cancer Inst; 1974 May; 52(5):1445-53. PubMed ID: 4208712
    [No Abstract]   [Full Text] [Related]  

  • 28. Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies.
    Robak T; Korycka A
    Arch Immunol Ther Exp (Warsz); 1987; 35(1):33-42. PubMed ID: 3477133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation and reactivity of leukaemic cells in acute myeloid leukaemia.
    Pegrum GD; Evans CA; Middleton VL
    Acta Haematol; 1974; 51(3):129-39. PubMed ID: 4281988
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia.
    Piccaluga PP; Luatti S; Ascani S; Bianchini M; Malagola M; Rondoni M; Gaitani S; Testoni N; Pileri SA; Baccarani M; Martinelli G; Visani G
    Cancer Genet Cytogenet; 2004 May; 151(1):85-6. PubMed ID: 15120916
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification of group B in acute myeloid leukaemia.
    Undevia JV; Bhatia HM; Sharma RS; Parekh JG
    Indian J Med Res; 1966 Dec; 54(12):1145-9. PubMed ID: 5231698
    [No Abstract]   [Full Text] [Related]  

  • 32. Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens.
    Gangal SG; Damle NK; Khare AG; Advani SH
    Br J Cancer; 1979 Sep; 40(3):391-6. PubMed ID: 292450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukaemia antigens: mixed leucocyte culture tests on twelve leukaemic patients with identical twins.
    Fefer A; Mickelson E; Thomas ED
    Clin Exp Immunol; 1974 Oct; 18(2):237-42. PubMed ID: 4283118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberration antigen expression in adult acute myelocytic leukemias.
    Chen SS; Zhang HF; Xue WT; Li K; Fu JF; Wang DB; Wu PN
    Chin Med J (Engl); 1993 Jun; 106(6):419-22. PubMed ID: 8222892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The absence of B-cell antigen B2 from leukaemia cells and lymphoblastoid cell lines.
    Billing RJ; Terasaki PI; Honig R; Peterson P
    Lancet; 1976 Jun; 1(7974):1365-7. PubMed ID: 59011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation antigens of HL-60 promyelocytes during induced maturation.
    Chiao JW; Wang CY
    Cancer Res; 1984 Mar; 44(3):1031-3. PubMed ID: 6581865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
    Li X; Du W; Liu W; Li X; Li H; Huang SA
    APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
    Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
    Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harnessing the immune system in acute myeloid leukaemia.
    Austin R; Smyth MJ; Lane SW
    Crit Rev Oncol Hematol; 2016 Jul; 103():62-77. PubMed ID: 27247119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies reactive with human myeloid leukaemia cells.
    Ball ED; Fanger MW
    Clin Exp Immunol; 1982 Jun; 48(3):655-65. PubMed ID: 6956470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.